ImageneBio, Inc. Cash and Restricted Cash
ImageneBio, Inc. (IMA) had Cash and Restricted Cash of $94.68 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94.68M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76.05M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94.53M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $103.16M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $94.68M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $76.05M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $94.53M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $103.16M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.02M 10-Q · filed 2026-08-05 | $59.16M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $4.92M 10-Q · filed 2026-05-07 | $37.63M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $12.12M 10-Q · filed 2026-08-05 | $40.27M 10-K · filed 2025-03-06 |
| 2024-09-30 | $8.73M 10-Q · filed 2025-11-12 | $46.06M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $45.55M 10-Q · filed 2025-07-24 | |
| 2024-03-31 | $54.13M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $15.32M 10-K · filed 2026-03-10 | $121.17M 10-K · filed 2024-03-12 |
| 2023-09-30 | $122.56M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $71.74M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $30.20M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $60.79M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $67.95M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $49.36M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $47.75M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $233.09M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $246.77M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $264.88M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $281.88M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $163.36M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $56.73M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $64.40M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $72.11M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $82.08M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |